Cargando…

Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine Development

Vaccines can be extremely cost-effective public health measures. Unfortunately the research and development (R&D) of novel vaccines is suffering from rising costs and declining success rates. Because many vaccines target low- and middle income markets (LMIC), output needs to be maintained at a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Roestenberg, Meta, Kamerling, Ingrid M. C., de Visser, Saco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215823/
https://www.ncbi.nlm.nih.gov/pubmed/30420951
http://dx.doi.org/10.3389/fmed.2018.00297